-transparent.png){kind=logo}
Thiopurine methyltransferase (TPMT) catalyzes the S-methylation of thiopurine drugs such as 6-mercaptopurine (6-MP) and 6-thioguanine (6-TG). A genetic polymorphism regulating TPMT activity in human tissue is an important factor responsible for individual differences in the toxicity and therapeutic efficacy of these drugs. Because of the clinical importance of this polymorphism, we studied 18 purine derivatives, including ribonucleosides and ribonucleotides, as potential substrates for purified human kidney TPMT. Sixteen of the compounds studied were substrates for the enzyme, with Km values that varied from 29.1 to 1270 microM and with Vmax values that varied from 75 to 2340 U/mg protein. The thiopurines tested had Km values that were uniformly lower than were those of the corresponding ribonucleosides or ribonucleotides. 6-Selenopurine derivatives had the lowest Km values of the compounds studied. Finally, oxidized purines with an OH in the 8-position were methylated by the enzyme, but 2-OH compounds were potent inhibitors of TPMT.
M Deininger, and
C L Szumlanski, and
D M Otterness, and
J Van Loon, and
W Ferber, and
R M Weinshilboum
January 1998,
Life sciences,
M Deininger, and
C L Szumlanski, and
D M Otterness, and
J Van Loon, and
W Ferber, and
R M Weinshilboum
March 1986,
Journal of medicinal chemistry,
M Deininger, and
C L Szumlanski, and
D M Otterness, and
J Van Loon, and
W Ferber, and
R M Weinshilboum
January 1999,
Nucleosides & nucleotides,
M Deininger, and
C L Szumlanski, and
D M Otterness, and
J Van Loon, and
W Ferber, and
R M Weinshilboum
November 1983,
Molecular pharmacology,
M Deininger, and
C L Szumlanski, and
D M Otterness, and
J Van Loon, and
W Ferber, and
R M Weinshilboum
August 1982,
Biochemical genetics,
M Deininger, and
C L Szumlanski, and
D M Otterness, and
J Van Loon, and
W Ferber, and
R M Weinshilboum
January 1990,
Drug metabolism and disposition: the biological fate of chemicals,
M Deininger, and
C L Szumlanski, and
D M Otterness, and
J Van Loon, and
W Ferber, and
R M Weinshilboum
July 1997,
Clinical pharmacology and therapeutics,
M Deininger, and
C L Szumlanski, and
D M Otterness, and
J Van Loon, and
W Ferber, and
R M Weinshilboum
July 1993,
The Journal of pharmacology and experimental therapeutics,
M Deininger, and
C L Szumlanski, and
D M Otterness, and
J Van Loon, and
W Ferber, and
R M Weinshilboum
March 1983,
Biochemical pharmacology,
M Deininger, and
C L Szumlanski, and
D M Otterness, and
J Van Loon, and
W Ferber, and
R M Weinshilboum
April 2004,
Therapeutic drug monitoring,
